抗阿特朱单抗（Anti-Atezolizumab,靶点PD-L1）

Direct/InhibitoryELISA, 

抗奥马珠单抗(Anti-Omalizumab/Xolair,靶点humanIgE)

0.258

称呼

Non-inhibitory

矫捷度

A01978-40

产品编号

抗纳武单抗（Anti-Nivolumab/Opdivo，靶点PD-1）

DirectELISA,Immunogenicityassay

抗度普利尤单抗(Anti-Dupilumab/Dupixent,靶点IL-4Rα)

抗曲妥珠单抗（Anti-Trastuzumab/Herceptin,靶点HER2)

IC50(μg/ml)

N/A

Non-inhibitory

N/A

抗体产品»

Direct/Indirect/InhibitoryELISA,

A01998-40

  

0.295ng/ml

Anti-AtezolizumabAntibody(6B12),mAb,Mouse

产品编号

A01896-40

产品编号

抗贝伐单抗（Anti-Bevacizumab/Avastin，靶点VEGF）

Direct/InhibitoryELISA,

N/A

MonoRab™Anti-PembrolizumabAntibody(90G12F8)[Biotin],mAb,Rabbit

Anti-DurvalumabAntibody(7B6),mAb,Mouse

Anti-DaratumumabAntibody(11F2),mAb,Mouse

产品编号

半抑制率

抗伊匹单抗（Anti-Ipilimumab，靶点CTLA-4）

Anti-IpilimumabAntibody(4H6E1D4)[Biotin],mAb,Mouse

称呼

A02037-40

N/A

免疫原性分析：配体中和实行和抗体阻断实行的比拟

半抑制率

运用举荐

A01970-40

A01949-40

DetectionantibodyforRituximab,PK/PDbridgingELISAwithA01942-40

抗体结合区特异性

Direct/IndirectELISA,

人的血清/血浆（EDTA抗凝），小鼠的血清，大鼠血清/血浆（肝素抗凝），兔血清/血浆（肝素抗凝）

关注微信群众号

Direct/IndirectELISA,

A01975-40

运用举荐

IC50(μg/ml)

Anti-BevacizumabAntibody,pAb,Rabbit

N/A

Anti-TocilizumabAntibody,pAb,Rabbit

运用举荐

Immunogenicityassay

CaptureantibodyforTocilizumabPK/PDbridgingELISAwithA01979-40

IndirectELISA,

0.38

特性

半抑制率IC50(μg/ml)

Direct/IndirectELISA,CaptureantibodyforDaratumumab,PK/PDbridgingELISAwithA01997-40

Anti-PembrolizumabAntibody,pAb,Rabbit

A01845-40

Non-inhibitory

DetectionantibodyforIpilimumab,PK/PDbridgingELISAwithA01859-40

CaptureantibodyforRituximab,PK/PDbridgingELISAwithA01970-40

DetectionantibodyforBevacizumab,PK/PDbridgingELISAwithA01895-40

称呼

A02035-40

非阻断

Anti-ObinutuzumabAntibody(16B7),mAb,Mouse

运用

Non-inhibitory

A01961-40

Anti-IpilimumabAntibody(26B6H7D9),mAb,Mouse

抗德瓦鲁单抗（Anti-Durvalumab/Imfinzi,靶点CD274)

运用举荐

运用举荐

A01942-40

Anti-DurvalumabAntibody(4B5),mAb,Mouse

Non-inhibitory

N/A

半抑制率IC50(μg/ml)

半抑制率

产品编号

Anti-NivolumabAntibody,pAb,Rabbit

半抑制率

Direct/IndirectELISA,

N/A

Anti-RituximabAntibody(17B6),mAb,Mouse

运用举荐

Direct/Indirect/InhibitoryELISA,

Anti-RanibizumabAntibody,pAb,Rabbit

IC50(μg/ml)

0.017

IC50(μg/ml)

称呼

Anti-AdalimumabAntibody,pAb,Rabbit

Direct/IndirectELISA

DetectionantibodyforObinutuzumab,PK/PDbridgingELISAwithA01966-40

Direct/IndirectELISA,

A01922-40

运用举荐

Anti-TocilizumabAntibody(14B10),mAb,Mouse

Immunogenicityassay

A01945-40

0.85

抗托株单抗（Anti-Tocilizumab，靶点TNF）

抗抗炎药单抗（Anti-Sarilumab/Kevzara,靶点IL-6R）

0.2073

Direct/IndirectELISA,

  

Non-inhibitory

MonoRab™Anti-RituximabAntibody(194D7)[Biotin],mAb,Rabbit

产品编号

Direct/IndirectELISA,

IC50(μg/ml)

Anti-DaratumumabAntibody(6A3),mAb,Mouse

Direct/IndirectELISA,

称呼

DetectionantibodyforObinutuzumab,PK/PDbridgingELISAwithA01966-40

DirectELISA,

N/A

A01886-40

N/A

CaptureantibodyforSarilumab,PK/PDbridgingELISAwithA02043-40

A01931-40

Anti-AdalimumabAntibody(3C2)[Biotin],mAb,Mouse

Anti-DurvalumabAntibody(15D6),mAb,Mouse

A01977-40

A01943-40

产品编号

Anti-BevacizumabAntibody(6C3),mAb,Mouse

Anti-RituximabAntibody,pAb,Rabbit

A01847-40

DetectionantibodyforNivolumab,PK/PDbridgingELISAwithA01847-40

抗奥滨尤妥珠单抗（Anti-Obinutuzumab/Gazyva，靶点CD20）

抗奥滨尤妥珠单抗（Anti-Obinutuzumab，靶点CD20）

MonoRab™Anti-BevacizumabAntibody(30E1),mAb,Rabbit

抗达雷木单抗（Anti-Daratumumab/Darzalex,靶点CD38）

IndirectELISA,

A02029-40

抗伊匹单抗（Anti-Ipilimumab/Yervoy，靶点CTLA-4）

MonoRab™Anti-BevacizumabAntibody(46E3),mAb,Rabbit

运用举荐

N/A

CaptureantibodyforDurvalumab,PK/PDbridgingELISAwithA02030-40

A01848-40

半抑制率

A01887-40

运用

Non-inhibitory

N/A

A01980-40

IndirectELISA,

A01846-40

IC50(μg/ml)

Indirect/InhibitoryELISA,

Anti-BevacizumabAntibody(4H1),mAb,Mouse

抗原结合性

Direct/IndirectELISA,

帕博利珠单抗（Pembrolizumab）用于生物仿制药免疫原性检测的原理图

一抗»

DetectionantibodyforDaratumumab,PK/PDbridgingELISAwithA01996-40

Anti-PembrolizumabAntibody(1D6E10),mAb,Mouse

Direct/Indirect/InhibitoryELISA,

Anti-CetuximabAntibody(20H1),mAb,Mouse

A01997-40

DirectELISA,Immunogenicityassay

Anti-ObinutuzumabAntibody(16B7)[Biotin],mAb,Mouse

A01895-40

产品编号

Direct/IndirectELISA,

Non-inhibitory

特性

DetectionantibodyforBevacizumab,PK/PDbridgingELISAwithA01895-40

Direct/IndirectELISA,

Anti-InfliximabAntibody(27A4),mAb,Mouse

人的血清/血浆，小鼠的血清/血浆

DetectionantibodyforTrastuzumab,PK/PDbridgingELISAwithA02032-40 

MonoRab™单克隆抗体检测矫捷度可达皮摩尔量级

Anti-PembrolizumabAntibody(10E12C6)[Biotin],mAb,Mouse

A02032-40

抗西妥昔单抗（Anti-Cetuximab，靶点EGFR）

Direct/InhibitoryELISA

A01858-40

Direct/InhibitoryELISA,

Direct/InhibitoryELISA, 

Indirect/InhibitoryELISA,

半抑制率

检测范围

IndirectELISA,

产品编号

称呼

Detectionantibodyforpembrolizumab,PK/PDbridgingELISAwithA01844

Anti-ObinutuzumabAntibody,pAb,Rabbit

抗英夫利昔单抗（Anti-Infliximab/Remicade,靶点TNF-α）

A01950-40

Immunogenicityassay

抗度普利尤单抗(Anti-Dupilumab/Dupixent,靶点IL-4Rα)

Anti-DaratumumabAntibody(9A6),mAb,Mouse

N/A

A02064-40

Non-inhibitory

IC50(μg/ml)

CaptureantibodyforAdalimumabPK/PDbridgingELISAwithA01922-40

IC50(μg/ml)

DetectionantibodyforNivolumab,PK/PDbridgingELISAwithA01847-40

半抑制率

抗纳武单抗（Anti-Nivolumab，靶点PD-1）

IC50(μg/ml)

MonoRab™Anti-PembrolizumabAntibody(90G12),mAb,Rabbit 

DirectELISA,Immunogenicityassay

抗派姆单抗（Anti-Pembrolizumab/Keytruda，靶点PD-1）

MonoRab™Anti-RituximabAntibody(137C6),mAb,Rabbit

产品编号

Direct/InhibitoryELISA, 

Direct/InhibitoryELISA

A01956-40

抗派姆单抗（Anti-Pembrolizumab，靶点PD-1）

A01853-40

0.582

IC50(μg/ml)

称呼

DetectionantibodyforAdalimumab,PK/PDbridgingELISAwithA01954-40

DetectionantibodyforIpilimumab,PK/PDbridgingELISAwithA01859-40

Direct/IndirectELISA,

CaptureantibodyforBevacizumabPK/PDbridgingELISAwithA01976-40

0.353

MonoRab™Anti-ObinutuzumabAntibody(169F10),mAb,Rabbit

Non-inhibitory

检测范围广，浓度结果精确

Direct/Indirect/InhibitoryELISA,

帕博利珠单抗（Pembrolizumab）的PK检测原理图（用小鼠抗Pembrolizumab单克隆抗体（A01844）作为捕获抗体，

Non-inhibitory

抗西妥昔单抗（Anti-Cetuximab/Erbitux，靶点EGFR）

Non-inhibitory

产品编号

运用举荐

DirectELISA,

半抑制率

A01962-40

0.175

DirectELISA,

Direct/InhibitoryELISA, 

N/A

0.046

IC50(μg/ml)

产品编号

Detectionantibodyforpembrolizumab,PK/PDbridgingELISAwithA01852

Anti-IpilimumabAntibody(4H6),mAb,Mouse

运用举荐

Anti-InfliximabAntibody(23H5),mAb,Mouse

CaptureantibodyforTrastuzumab,PK/PDbridgingELISAwithA02033-40

A02036-40

产品编号

Direct/IndirectELISA,

抗配合型抗体（Anti-idiotypeantibody,Anti-IDAbs）是针统一体可变区的抗原决定簇（配合型）发作的特异性抗体。抗配合型抗体被广泛用于临床前研讨和临床开拓中抗体药物含量的测定（包括：游离型、结合型和总量）。在医学研讨中，被用于疫苗及抗体药物的免疫原性（immunogenicity）分析。

Direct/IndirectELISA,

测试样品

运用举荐

Non-inhibitory

半抑制率IC50（µg/ml）

QQ：2885349184；qq:2412872306

Direct/IndirectELISA,

CaptureantibodyforRanibizumab,PK/PDbridgingELISAwithA02036-40

A02031-40

抗帕利珠单抗(Anti-Palivizumab/Synagis,靶点RSVF)

产品编号

运用举荐

Immunogenicityassay

N/A

Direct/IndirectELISA,

Anti-ObinutuzumabAntibody(18H8),mAb,Mouse

A01996-40

Indirect/InhibitoryELISA,

IC50(μg/ml)

N/A

CaptureantibodyforObinutuzumabPK/PDbridgingELISAwithA01967-40

CaptureantibodyforIpilimumab,PK/PDbridgingELISAwithA01858-40

产品编号

A01965-40

MonoRab™Anti-ObinutuzumabAntibody(8G12),mAb,Rabbit

0.04616

fmvqafhnwv@126.com；《产品订单提交模板》下载

Anti-TrastuzumabAntibody(11C4),mAb,Mouse

矫捷度

抗阿达木单抗（Anti-Adalimumab/Humira，靶点TNFα）

A01969-40

IC50(μg/ml)

MonoRab™Anti-AdalimumabAntibody(4E12),mAb,Rabbit

Non-inhibitory

A01948-40

Anti-CetuximabAntibody(18D5),mAb,Mouse

Direct/IndirectELISA,

产品编号

Non-inhibitory

抗阿特朱单抗（Anti-Atezolizumab/Tecentriq，靶点PD-L1）

用Biotin标记的小鼠抗Pembrolizumab单克隆抗体（A01845）作为检测抗体。）

1.37

Direct/IndirectELISA,

CaptureantibodyforNivolumab,PK/PDbridgingELISAwithA01848-40

Detectionantibodyforpembrolizumab,PK/PDbridgingELISAwithA01852

Anti-PalivizumabAntibody,pAb,Rabbit

A02062-40

Anti-DurvalumabAntibody,pAb,Rabbit

称呼

Anti-SarilumabAntibody(20F5),mAb,Mouse

MonoRab™Anti-AdalimumabAntibody(134D5),mAb,Rabbit

A02010-40

N/A

IndirectELISA,

DetectionantibodyforSarilumab,PK/PDbridgingELISAwithA02042-40 

CaptureantibodyforCetuximab,PK/PDbridgingELISAwithA01938-40

Anti-OmalizumabAntibody,pAb,Rabbit

A02044-40

半抑制率

产品编号

A01921-40

Anti-RanibizumabAntibody(10D12),mAb,Mouse

Direct/InhibitoryELISA

Indirect/InhibitoryELISA,

DetectionantibodyforObinutuzumab,PK/PDbridgingELISAwithA01945-40

A01954-40

N/A

DetectionantibodyforAdalimumab,PK/PDbridgingELISAwithA01921-40

Direct/IndirectELISA,

DetectionantibodyforDurvalumab,PK/PDbridgingELISAwithA02029-40

  

Direct/IndirectELISA,

称呼

0.056

Anti-TocilizumabAntibody(6C10),mAb,Mouse

随着仿制药的出现，使得患者可以享用担负得起的创新药。GenScript消耗出种种典范的针对重磅药物的抗配合型抗体，助力仿制药的研发。

A02060-40

0.37

Anti-AdalimumabAntibody(3C2),mAb,Mouse

了解产品概略

DirectELISA,

Non-inhibitory

抗托株单抗（Anti-Tocilizumab/Actemra，靶点IL-6R）

用兔抗Pembrolizumab多克隆抗体（A01846）作为阳性比拟，绘制标准曲线

N/A

IndirectELISA,

半抑制率

Anti-RituximabAntibody(17B6)[Biotin],mAb,Mouse

Anti-TocilizumabAntibody(6C10)[Biotin],mAb,Mouse

运用举荐

抗抗炎药单抗（Anti-Sarilumab/Kevzara,靶点IL-6R）

CaptureantibodyforRituximab,PK/PDbridgingELISAwithA01943-40

Anti-SarilumabAntibody(26B10),mAb,Mouse

Kd

Anti-NivolumabAntibody(8G6G3D8),mAb,Mouse

抗达雷木单抗（Anti-Daratumumab/Darzalex,靶点CD38)

MonoRab™Anti-Daratumumab(139B10),mAb,Rabbit

DetectionantibodyforObinutuzumab,PK/PDbridgingELISAwithA01945-40

称呼

A02030-40

检测范围

Direct/IndirectELISA,

检测结合型和总量

A01859-40

A01966-40

DirectELISA,

DetectionantibodyforCetuximab,PK/PDbridgingELISAwithA01939-40

CaptureantibodyforInfliximab,PK/PDbridgingELISAwithA02041-40

0.062

DetectionantibodyforRituximab,PK/PDbridgingELISAwithA01969-40

Direct/IndirectELISA,

半抑制率

抗雷珠单抗（Anti-Ranibizumab/Lucentis,靶点VEGF)

配对的抗配合型抗体，可用于SandwichELISA检测

0.118

产品编号

Immunogenicityassay

Non-inhibitory

IndirectELISA,

DetectionantibodyforTocilizumab,PK/PDbridgingELISAwithA01978-40

0.38

无抑制性

A01971-40

产品选择辅导

半抑制率

称呼

抗利妥昔单抗（Anti-Rituximab/Rituxan，靶点CD20）

目录产品»

Anti-NivolumabAntibody(6G5),mAb,Mouse

N/A

称呼

Non-inhibitory

A02033-40

0.118

Direct/IndirectELISA,

Direct/IndirectELISA,

运用举荐

运用举荐

Anti-AtezolizumabAntibody(6B12)[Biotin],mAb,Mouse

A01955-40

Immunogenicityassay

CaptureantibodyforAtezolizumabPK/PDbridgingELISAwithA01949-40

1.56-100ng/ml

A01979-40

A01967-40

N/A

Non-inhibitory

N/A

Direct/Indirect/InhibitoryELISA,

Anti-AdalimumabAntibody(15C7),mAb,Mouse

0.20ng/ml

抗奥马珠单抗(Anti-Omalizumab/Xolair,靶点humanIgE)

N/A

N/A

Direct/IndirectELISA,

A01960-40

A02043-40

称呼

Non-inhibitory

Non-inhibitory

抗曲妥珠单抗（Anti-Trastuzumab/Herceptin,靶点HER2）

测试样品

N/A

抗配合型（Anti-idiotype）抗体

N/A

MonoRab™Anti-AdalimumabAntibody(196F3),mAb,Rabbit

DetectionantibodyforTocilizumab,PK/PDbridgingELISAwithA01978-40

N/A

Immunogenicityassay

DirectELISA,

称呼

DirectELISA,

半抑制率

A01946-40

1.56-100ng/ml

称呼

抗利妥昔单抗（Anti-Rituximab，靶点CD20）

DetectionantibodyforAtezolizumab,PK/PDbridgingELISAwithA01948-40

CaptureantibodyforBevacizumab,PK/PDbridgingELISAwithA01896-40

注册会员，在线提交订单，物流随时盘诘

A01939-40

半抑制率IC50(μg/ml)

N/A

称呼

运用举荐

DetectionantibodyforBevacizumab,PK/PDbridgingELISAwithA01975-40

Anti-AtezolizumabAntibody(10G9),mAb,Mouse

DetectionantibodyforAdalimumab,PK/PDbridgingELISAwithA01954-40

运用举荐

DetectionantibodyforRituximab,PK/PDbridgingELISAwithA01942-40

非抗体结合区特异性

Non-inhibitory

Immunogenicityassay

A02009-40

运用举荐

典范

Anti-TrastuzumabAntibody(15H2),mAb,Mouse

DetectionantibodyforRituximab,PK/PDbridgingELISAwithA01969-40

Direct/IndirectELISA,

MonoRab™Anti-RituximabAntibody(194D7),mAb,Rabbit

抗帕利珠单抗(Anti-Palivizumab/Synagis,靶点RSVF)

DetectionantibodyforAtezolizumab,PK/PDbridgingELISAwithA01948-40

抗原阻断

Direct/IndirectELISA,

CaptureantibodyforAdalimumabPK/PDbridgingELISAwithA01955-40

运用举荐

Indirect/InhibitoryELISA,

原理图

称呼

N/A

抗雷珠单抗（Anti-Ranibizumab/Lucentis,靶点VEGF）

抗体药物的药代动力学（PK）和药效动力学（PD）分析

  

抗阿达木单抗（Anti-Adalimumab,靶点TNFα）

N/A

A01976-40

称呼

A01844-40

Direct/InhibitoryELISA, 

A02041-40

DirectELISA,

DetectionantibodyforObinutuzumab,PK/PDbridgingELISAwithA01945-40

Captureantibodyforpembrolizumab,PK/PDbridgingELISAwithA01845

Immunogenicityassay

A01944-40

Anti-SarilumabAntibody(23H12),mAb,Mouse

A02040-40

A01938-40

Anti-RituximabAntibody(6C1),mAb,Mouse

Non-inhibitory

Anti-NivolumabAntibody(6G5H2E6)[Biotin],mAb,Mouse

MonoRab™Anti-BevacizumabAntibody(46E3)[Biotin],mAb,Rabbit

A01947-40

N/A

称呼

A01923-40

IC50(μg/ml)

Anti-DupilumabAntibody,pAb,Rabbit

MonoRab™Anti-ObinutuzumabAntibody(169F10)[Biotin],mAb,Rabbit

IC50(μg/ml)

MonoRab™兔抗Pembrolizumab单克隆抗体(克隆ID：90G12F8)（货号：A01853）亲和力

CaptureantibodyforObinutuzumabPK/PDbridgingELISAwithA01946-40

抗英夫利昔单抗（Anti-Infliximab/Remicade,靶点TNF-α）

抗配合型（Anti-idiotype）抗体

检测游离型的抗体

产品编号

A02042-40

抑制性或中和性

IndirectELISA,

DetectionantibodyforInfliximab,PK/PDbridgingELISAwithA02040-40

半抑制率

A01932-40

抗德瓦鲁单抗（Anti-Durvalumab/Imfinzi,靶点CD274)

DirectELISA,

400-025-8686-5810/5256/5103

A01933-40

DetectionantibodyforBevacizumab,PK/PDbridgingELISAwithA01975-40

IndirectELISA,

A01918-40

DirectELISA,Immunogenicityassay

抗贝伐单抗（Anti-Bevacizumab，靶点VEGF）

Anti-BevacizumabAntibody(6C3)[Biotin],mAb,Mouse

A01968-40

半抑制率

Anti-RanibizumabAntibody(6C3),mAb,Mouse